Clinical Trial Update: Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating antioxidants for MRI-detectable changes in early stage prostate cancer among men on active surveillance; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostatic Neoplasms

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cancer of the Prostate, Prostate Cancer | Phase 2 | Status: COMPLETED